Ignite Creation Date:
2025-12-24 @ 5:48 PM
Ignite Modification Date:
2026-01-18 @ 7:17 PM
Study NCT ID:
NCT04814368
Status:
TERMINATED
Last Update Posted:
2025-10-24
First Post:
2021-03-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Safety and Efficacy Study of Anti-inflammatory (Canakinumab) and Cartilage Stimulating (LNA043) Drugs Injected Into the Knee Joint of Participants With Knee Osteoarthritis (OA)
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-08-27
Start Date Type:
ACTUAL
Primary Completion Date:
2024-06-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-06-24
Completion Date Type:
ACTUAL
First Submit Date:
2021-03-22
First Submit QC Date:
None
Study First Post Date:
2021-03-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-06-10
Results First Submit QC Date:
None
Results First Post Date:
2025-07-30
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-08
Last Update Post Date:
2025-10-24
Last Update Post Date Type:
ESTIMATED